Cerebral Receives Grand Jury Subpoena From U.S. Attorney
- Company stopped writing new prescriptions for ADHD drugs
- Softbank-backed firm part of Covid boom in mental telehealth
This article is for subscribers only.
Cerebral Inc., the SoftBank-backed mental healthcare startup, is being investigated for possible violations of the Controlled Substances Act, a spokeswoman said in an emailed statement Saturday.
“To be clear, at this time, no regulatory or law enforcement authority has accused Cerebral of violating any law,” the spokeswoman said. “Cerebral intends to fully cooperate with the investigation.”